# Dopaminergic Loss and Pain in Parkinson's Disease

> **NCT00940914** · PHASE2 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 20 (actual)

## Conditions studied

- Parkinson's Disease
- Pain

## Interventions

- **DRUG:** ioflupane 123I (DATSCAN®)

## Key facts

- **NCT ID:** NCT00940914
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940914, "Dopaminergic Loss and Pain in Parkinson's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00940914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*